Yang Liu
Harbin Medical University
8 Papers
Yang Liu is an academic researcher from Harbin Medical University. The author has contributed to research in topics: Lung cancer & Gene signature. The author has an hindex of 4, co-authored 8 publications.
Chat about Author
Papers
Prognostic Implications of Autophagy-Associated Gene Signatures in Non-Small Cell Lung Cancer
Yang Liu,Ligao Wu,Haijiao Ao,Meng Zhao,Xue Leng,Mingdong Liu,Jianqun Ma,Jinhong Zhu +7 more
- 07 Dec 2019
TL;DR: A novel autophagy-associated gene signature is constructed and verified that could improve the individualized outcome prediction in NSCLC and constructed a clinical nomogram with a concordance index of 0.71 to predict the survival possibility ofNSCLC patients by integrating clinical characteristics and the autophagic gene signature.
143
Contributions and prognostic values of m 6 A RNA methylation regulators in non‐small‐cell lung cancer
Yang Liu,Xiuchen Guo,Meng Zhao,Haijiao Ao,Xue Leng,Mingdong Liu,Caixia Wu,Jianqun Ma,Jinhong Zhu +8 more
TL;DR: An optimal prognostic gene signature could better predict prognosis in the late‐stage of NSCLC than in the early‐stage LUAD and was developed by using the least absolute shrinkage and selection operator Cox regression algorithm and compute risk score.
47
XPG rs17655 G>C polymorphism associated with cancer risk: evidence from 60 studies.
Jie Zhao,Shanshan Chen,Haixia Zhou,Ting Zhang,Yang Liu,Jing He,Jing He,Jinhong Zhu,Jichen Ruan +8 more
- 20 May 2018
TL;DR: A comprehensive meta-analysis of 60 case-control studies indicated that the XPG gene rs17655 G>C polymorphism was associated with increased overall cancer risk, especially the risk of gastric cancer and colorectal cancer.
UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma
TL;DR: In this article, the authors explored several public databases, including The Cancer Genome Atlas (TCGA), Oncomine, and gene expression Omnibus (GEO), to explore involved signaling pathways and found significantly increased UBE2T transcript levels and DNA copy numbers in ESCC tissues.
Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer.
TL;DR: Comparing the profiles of immune cells in cancerous and normal tissues in The Cancer Genome Atlas (TCGA) lung cancer cohorts and establishing multiple-gene risk prediction signatures using the Cox regression model provided evidence of ACK1's implication in tumor immunity, suggesting that ACK 1 may be a potential immunotherapeutic target for non-small cell lung cancer (NSCLC).